Koh Ono

Title: Koh Ono: Innovator in Cardiomyocyte and Neurodegenerative Disease Research

Introduction

Koh Ono is a distinguished inventor based in Kyoto, Japan. He has made significant contributions to the fields of cardiomyocyte protection and neurodegenerative disease treatment. With a total of 3 patents, his work is recognized for its potential impact on medical therapies.

Latest Patents

One of Koh Ono's latest patents is a composition for protecting cardiomyocytes. The inventors have discovered that the compounds of formula (I) protect cardiomyocytes. This pharmaceutical composition may be used for treating or preventing diseases associated with cardiomyocyte death, such as myocardial infarction, chronic heart failure, hypertensive heart failure, or dilated cardiomyopathy, with a particular focus on treating myocardial infarction. Another significant patent involves a composition for preventing or treating neurodegenerative diseases. This invention aims to provide a therapeutic agent for hereditary spastic paraplegia (HSP) SPG4. The composition comprises a substance that inhibits the function of miR-33a as an active ingredient.

Career Highlights

Koh Ono is affiliated with Kyoto University, where he conducts his research and development. His work has garnered attention for its innovative approaches to complex medical challenges.

Collaborations

Some of his notable coworkers include Takahiro Horie and Haruhisa Inoue, who contribute to the collaborative efforts in his research projects.

Conclusion

Koh Ono's contributions to the fields of cardiomyocyte protection and neurodegenerative disease treatment highlight his innovative spirit and dedication to advancing medical science. His patents reflect a commitment to improving health outcomes for patients facing serious medical conditions.